Abbott Laboratories
NYSE:ABT

Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist
Price: 127.21 USD 0.69% Market Closed
Market Cap: 220.6B USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one ABT stock under the Base Case scenario is 129.87 USD. Compared to the current market price of 127.21 USD, Abbott Laboratories is Undervalued by 2%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ABT Relative Value
Base Case
129.87 USD
Undervaluation 2%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

5.3
P/S
P/S
Price to Sales
5.3
vs History
20
vs Industry
29
Median 3Y
4.5
Median 5Y
4.7
Industry
2.3
Forward
4.9
More Details
16.4
P/E
P/E
Price to Earnings
16.4
vs History
96
vs Industry
17
Median 3Y
30.1
Median 5Y
32.5
Industry
22.7
Forward
24.4
More Details
25.7
P/OCF
P/OCF
Price to OCF
25.7
vs History
19
vs Industry
16
Median 3Y
22.9
Median 5Y
22.9
Industry
13.8
More Details
47.3
P/FCFE
P/FCFE
Price to FCFE
47.3
vs History
30
vs Industry
8
Median 3Y
34
Median 5Y
34.8
Industry
19.6
More Details
4.6
P/B
P/B
Price to Book Value
4.6
vs History
80
vs Industry
18
Median 3Y
4.9
Median 5Y
5
Industry
2.2
More Details
5.4
EV/S
EV/S
Enterprise Value to Sales
5.4
vs History
22
vs Industry
26
Median 3Y
4.6
Median 5Y
4.8
Industry
2.4
Forward
5
More Details
9.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
9.7
vs History
22
vs Industry
26
Median 3Y
8.3
Median 5Y
8.7
Industry
5
More Details
22
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
22
vs History
15
vs Industry
18
Median 3Y
18.5
Median 5Y
19.4
Industry
12
Forward
18.7
More Details
32.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
32.2
vs History
22
vs Industry
15
Median 3Y
27.7
Median 5Y
28.8
Industry
16.5
Forward
21.7
More Details
26.3
EV/OCF
EV/OCF
Enterprise Value to OCF
26.3
vs History
25
vs Industry
15
Median 3Y
23.4
Median 5Y
23.4
Industry
13.5
More Details
35.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
35.4
vs History
34
vs Industry
12
Median 3Y
32.5
Median 5Y
32.5
Industry
17
More Details
3.2
EV/IC
EV/IC
Enterprise Value to IC
3.2
vs History
34
vs Industry
27
Median 3Y
3.2
Median 5Y
3.2
Industry
1.9
More Details

Multiples Across Competitors

ABT Competitors Multiples
Abbott Laboratories Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Abbott Laboratories
NYSE:ABT
220.3B USD 5.3 16.4 22 32.2
US
Intuitive Surgical Inc
NASDAQ:ISRG
181.1B USD 21.7 78 60.5 73.4
US
Boston Scientific Corp
NYSE:BSX
151.3B USD 9 81.6 37.3 52.6
US
Stryker Corp
NYSE:SYK
142.7B USD 6.3 47.7 24.7 29.8
IE
Medtronic PLC
NYSE:MDT
115.7B USD 3.5 27.2 14.4 20.4
US
Becton Dickinson and Co
NYSE:BDX
66.5B USD 3.2 38 15.8 28.5
DE
Siemens Healthineers AG
XETRA:SHL
57.8B EUR 2.5 29.1 16.6 23.6
US
Edwards Lifesciences Corp
NYSE:EW
42B USD 7.7 10.1 23.6 26.1
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
291B CNY 7.8 23.5 20.5 20.5
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
37.3B USD 1.9 18.7 13.1 16
US
IDEXX Laboratories Inc
NASDAQ:IDXX
34.6B USD 8.9 38.9 27.7 30.9

See Also

Summary
ABT intrinsic value, competitors valuation, and company profile.
DCF Valuation
ABT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ABT stock valuation using valuation multiples.
Wall Street Estimates
ABT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ABT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 241,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.